0001437749-21-009856.txt : 20210427
0001437749-21-009856.hdr.sgml : 20210427
20210427083047
ACCESSION NUMBER: 0001437749-21-009856
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20210427
DATE AS OF CHANGE: 20210427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrne Joseph A.
CENTRAL INDEX KEY: 0001736911
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21856028
MAIL ADDRESS:
STREET 1: 6 CAMERON SIDE ROAD EAST
CITY: ESSEX
STATE: A6
ZIP: N8M 2X5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2018-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736911
Byrne Joseph A.
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
Chief Executive Officer*
Common Stock
2018-01-14
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-02-14
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-03-15
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-04-17
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-05-14
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-06-15
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-07-16
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-08-16
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-09-16
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-10-17
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-11-20
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-12-14
4
J
0
L
2000
0
A
1425265
D
Common Stock
2018-01-14
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-02-14
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-03-15
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-04-17
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-05-14
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-06-15
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-07-16
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-08-16
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-09-16
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-10-17
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-11-20
4
J
0
L
4000
0
A
1425265
I
By Spouse
Common Stock
2018-12-14
4
J
0
L
4000
0
A
1425265
I
By Spouse
24,000 shares of the issuer held by the reporting person were issued as consideration for extending the maturity date of a promissory note dated January 24, 2018 and were acquired in increments of 2,000 shares on the following dates: 12/14/18; 11/20/18; 10/17/18; 9/16/18; 8/16/18; 7/16/18; 6/15/18; 5/14/18; 4/17/18; 1/24/18; 2/14/18; and 3/15/18.
48,000 shares of common stock of the issuer were issued to the Reporting Person's spouse as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 4,000 on the following dates: 1/14/18; 2/14/18; 3/15/18; 4/17/18; 5/14/18; 6/15/18; 7/16/18; 8/16/18; 9/16/18; 10/17/18; 11/20/18; and 12/14/18.
1,377,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person and 48,000 shares were held by the Reporting Person's spouse at 12/31/2018.
*The reporting person served as the Chief Executive Officer and member of the Board of the Issuer from July 2017 until November 13, 2019, when the reporting person resigned from all positions with the Issuer. The reporting person was appointed as President and a member of the Board of the Issuer effective April 19, 2021.
/s/ Joseph Byrne
2021-04-27